Photo of Ales Bartl

On 18 May 2026, the European Commission launched a call for evidence related to the upcoming revision of EU Tobacco Products Directive 2014/40/EU (TPD). Feedback is open until 15 June 2026 and is open to everybody. In the meantime, public consultation, available to stakeholders including citizens, businesses, representative organisations and EU countries’ public authorities, academics

Photo of Azim ChowdhuryPhoto of Neelam Gill

On May 5, 2026, the U.S. Food and Drug Administration (FDA) issued marketing granted orders (MGOs) for four Glas closed-pod electronic nicotine delivery system (ENDS) products: Classic Menthol, Fresh Menthol, Gold (mango), and Sapphire (blueberry). The authorization is a significant development for the ENDS industry because the Gold and Sapphire are FDA’s first authorized non-tobacco

Keller and Heckman Tobacco and E-Vapor attorneys, led by Partner Azim Chowdhury, co-authored with Latham & Watkins the Food and Drug Law Institute (FDLI) 2026 publication, “Nicotine Delivery Products: Navigating FDA’s Policies and Regulations in a Dynamic Environment.” Counsel Neelam Gill and LieAnn Van-Tull also served as co-authors, while the following Keller and Heckman attorneys

Photo of Azim ChowdhuryPhoto of Kaitlyn Johnson

Pennsylvania has joined the growing group of states that condition ENDS sales on federal PMTA status. Enacted as Act 57 of 2025, House Bill 1425 adds Section 206-I to The Fiscal Code and directs the Pennsylvania Attorney General to maintain a directory of electronic cigarettes that may be sold in the Commonwealth. The law ties

Photo of Azim ChowdhuryPhoto of Neelam GillPhoto of Brian Frank

On December 19, 2025, FDA issued Marketing Granted Orders authorizing six on! PLUS oral nicotine pouches from Helix Innovations (Altria): Mint, Tobacco, and Wintergreen, each in 6 mg and 9 mg nicotine strengths. FDA framed these as the first decisions to come out of its nicotine-pouch PMTA pilot, designed to speed reviews without lowering

Photo of Azim Chowdhury

Save the date for Keller and Heckman’s 10th Annual E-Vapor, Nicotine, and Tobacco Law Symposium, taking place on May 4 – 5, 2026, in Las Vegas, NV, at the Paris Las Vegas hotel (right before the CHAMPS Trade Show)!

This two-day seminar is designed to provide in-depth knowledge on legal, regulatory, and scientific

Photo of Ales BartlPhoto of Azim Chowdhury

Update on EU Regulations of E-Vapor and Nicotine Pouches

Date: Thursday, 08 May 2025
Time: 4:30 PM – 5:30 PM CET | 10:30 AM – 11:30 AM EDT
Duration: 60 minutes
Cost: Complimentary
Registration: Click Here

Keller and Heckman LLP is pleased to announce a complimentary webinar, Update on EU Regulations of E-Vapor and Nicotine

Photo of Azim ChowdhuryPhoto of Neelam Gill

In a groundbreaking move, FDA has kicked off the year with its very first marketing authorization for an oral nicotine pouch product. On January 16, 2025, FDA authorized twenty ZYN nicotine pouch products, marketed by Swedish Match (a subsidiary of Philip Morris International), in two nicotine strengths, 3 mg and 6 mg. The newly authorized

Photo of Kathryn Skaggs

A wave of new “Extended Producer Responsibility” or “EPR” programs is beginning to impact companies placing packaged products, including tobacco products, on the market in U.S. states, including California, Colorado, Maine, Minnesota, and Oregon

The five EPR programs for packaging enacted thus far have different facets. However, at their core